Ubs Group Ag In8 Bio, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in In8 Bio, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 58,853 shares of INAB stock, worth $17,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,853
Previous 26,270
124.03%
Holding current value
$17,067
Previous $7,000
114.29%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
25.3MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX8.6MShares$2.49 Million2.31% of portfolio
-
Aigh Capital Management LLC Baltimore, MD6.19MShares$1.8 Million0.68% of portfolio
-
Franklin Resources Inc San Mateo, CA5.7MShares$1.65 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL5.06MShares$1.47 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$412,9300.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $7.11M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...